This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental material
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shirtliff, M. E.
Right arrow Articles by Jabra-Rizk, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shirtliff, M. E.
Right arrow Articles by Jabra-Rizk, M. A.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, June 2009, p. 2392-2401, Vol. 53, No. 6
0066-4804/09/$08.00+0     doi:10.1128/AAC.01551-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Farnesol-Induced Apoptosis in Candida albicans{triangledown} ,{dagger}

Mark E. Shirtliff,1,2,# Bastiaan P. Krom,3,# Roelien A. M. Meijering,3 Brian M. Peters,4 Jingsong Zhu,5 Mark A. Scheper,5 Megan L. Harris,1 and Mary Ann Jabra-Rizk5,6*

Department of Microbial Pathogenesis, Dental School, University of Maryland, Baltimore, Maryland,1 Department of Microbiology and Immunology, School of Medicine, University of Maryland, Baltimore, Maryland,2 Department of Biomedical Engineering, University Medical Center Groningen and University of Groningen, Groningen, Netherlands,3 Graduate Program in Life Sciences, Microbiology and Immunology Program, School of Medicine, University of Maryland, Baltimore, Maryland,4 Department of Oncology and Diagnostic Sciences, Dental School, University of Maryland, Baltimore, Maryland,5 Department of Pathology, School of Medicine, University of Maryland, Baltimore, Maryland6

Received 20 November 2008/ Returned for modification 12 December 2008/ Accepted 28 March 2009

Farnesol, a precursor in the isoprenoid/sterol pathway, was recently identified as a quorum-sensing molecule produced by the fungal pathogen Candida albicans. Farnesol is involved in the inhibition of germination and biofilm formation by C. albicans and can be cytotoxic at certain concentrations. In addition, we have shown that farnesol can trigger apoptosis in mammalian cells via the classical apoptotic pathways. In order to elucidate the mechanism behind farnesol cytotoxicity in C. albicans, the response to farnesol was investigated, using proteomic analysis. Global protein expression profiles demonstrated significant changes in protein expression resulting from farnesol exposure. Among the downregulated proteins were those involved in metabolism, glycolysis, protein synthesis, and mitochondrial electron transport and the respiratory chain, whereas proteins involved in folding, protection against environmental and oxidative stress, actin cytoskeleton reorganization, and apoptosis were upregulated. Cellular changes that accompany apoptosis (regulated cell death) were further analyzed using fluorescent microscopy and gene expression analysis. The results indicated reactive oxygen species accumulation, mitochondrial degradation, and positive terminal deoxynucleotidyltransferase-mediated dUTP-biotin nick end labeling (TUNEL) in the farnesol-exposed cells concurrent with increased expression of antioxidant-encoding and drug response genes. More importantly, the results demonstrated farnesol-induced upregulation of the caspase gene MCA1 and the intracellular presence of activated caspases. In conclusion, this study demonstrated that farnesol promotes apoptosis in C. albicans through caspase activation, implying an important physiological role for farnesol in the fungal cell life cycle with important implications for adaptation and survival.


* Corresponding author. Mailing address: Department of Oncology and Diagnostic Sciences, Dental School, University of Maryland, 650 W. Baltimore Street, 7 N, Room 2753, Baltimore, MD 21201. Phone: (410) 708-0508. Fax: (410) 706-0519. E-mail: mrizk{at}umaryland.edu

{triangledown} Published ahead of print on 13 April 2009.

{dagger} Supplemental material for this article may be found at http://aac.asm.org/.

# Both authors contributed equally.


Antimicrobial Agents and Chemotherapy, June 2009, p. 2392-2401, Vol. 53, No. 6
0066-4804/09/$08.00+0     doi:10.1128/AAC.01551-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.